Literature DB >> 10469245

Distribution of membrane cofactor protein (MCP/CD46) on pig tissues. Relevance To xenotransplantation.

J M Pérez de la Lastra1, S M Hanna, B P Morgan.   

Abstract

Membrane cofactor protein (MCP; CD46) is a 50-60 000 MW glycoprotein, expressed on a wide variety of cells and tissues in man, which plays an important role in regulating complement activation. Human MCP has also been shown to be the receptor for measles virus. We have recently identified the pig analogue of MCP and demonstrated that pig MCP has cofactor activity for factor I-mediated cleavage of C3b when these components are derived either from pig or human. As a consequence, pig MCP is an efficient regulator of the classic and alternative pathways of human and pig complement. In order to define the potential importance of MCP in protecting against complement activation in the pig, we have conducted a comprehensive survey of its distribution in pig cells and organs. As in humans, MCP in the pig is broadly and abundantly distributed. Pig MCP is highly expressed on all circulating cells, including erythrocytes, in contrast to its absence on human erythrocytes. Multiple isoforms of MCP are found on cells and in tissues, probably representing products of alternative splicing analogous to those found in man. MCP is abundantly expressed throughout all tissues examined with particularly strong staining on the vascular endothelium. Connective tissue elements within liver and testis are also strongly stained by anti-pig MCP antibodies. Pig MCP is expressed only weakly on skeletal muscle cells and expression is absent from smooth muscle cells in the lung and vessel walls, sites at which human MCP is expressed. Of particular note, MCP is not expressed in B-cell areas of the germinal centres of lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469245      PMCID: PMC2326893          DOI: 10.1046/j.1365-2567.1999.00830.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  37 in total

1.  Comparison between aortic and sinusoidal liver endothelial cells as targets of hyperacute xenogeneic rejection in the pig to human combination.

Authors:  P Cattan; B Zhang; F Braet; N Atia; F Conti; H Conjeaud; B Weill; C Chereau; D Houssin; Y Calmus
Journal:  Transplantation       Date:  1996-09-27       Impact factor: 4.939

2.  Molecular cloning of a pig homologue of membrane cofactor protein (CD46).

Authors:  K Toyomura; T Fujimura; H Murakami; T Natsume; T Shigehisa; N Inoue; J Takeda; T Kinoshita
Journal:  Int Immunol       Date:  1997-06       Impact factor: 4.823

3.  Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes.

Authors:  T Seya; L L Ballard; N S Bora; V Kumar; W Cui; J P Atkinson
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

4.  Epitope mapping of 10 monoclonal antibodies against the pig analogue of human membrane cofactor protein (MCP).

Authors:  J M Pérez De La Lastra; C W Van Den Berg; R Bullido; F Almazán; J Domínguez; D Llanes; B P Morgan
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

5.  Transgenic pigs and virus adaptation.

Authors:  R A Weiss
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

6.  Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP).

Authors:  C W van den Berg; J M Pérez de la Lastra; D Llanes; B P Morgan
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

7.  Molecular cloning of guinea pig membrane cofactor protein: preferential expression in testis.

Authors:  M Hosokawa; M Nonaka; N Okada; M Nonaka; H Okada
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

8.  Characterization in vitro and in vivo of the pig analogue of human CD59 using new monoclonal antibodies.

Authors:  S M Hanna; G T Williams; C W Van Den Berg; B P Morgan
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

Review 9.  The binding of immune complexes by the erythrocyte complement receptor 1 (CR1).

Authors:  M Pascual; J A Schifferli
Journal:  Immunopharmacology       Date:  1992 Sep-Oct

10.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

2.  Pig complement regulator factor H: molecular cloning and functional characterization.

Authors:  Guido A Hegasy; Ute Willhoeft; Sandra A Majno; Harald Seeberger; Peter F Zipfel; Jens Hellwage
Journal:  Immunogenetics       Date:  2003-09-27       Impact factor: 2.846

3.  Identification and expression profiling of blood-brain barrier membrane proteins.

Authors:  Nitin Agarwal; Ethan S Lippmann; Eric V Shusta
Journal:  J Neurochem       Date:  2009-11-06       Impact factor: 5.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.